Vowst's FDA approval is a boon for the prevention of recurrent Clostridioides difficile infection

被引:1
作者
Anand, Ayush [1 ,11 ]
Shaikh, Nameera Parveen [7 ,11 ]
Aggarwal, Yash [3 ,11 ]
Fatima, Umaima [4 ,11 ]
Chapagain, Sanskriti [2 ,11 ]
Chidurala, Rahul [6 ,11 ]
Vaghela, Jenish [5 ]
Surana, Arihant [8 ]
Parikh, Charmy [9 ]
Patel, Raj H. [10 ]
机构
[1] BP Koirala Inst Hlth Sci, Dharan 56700, Nepal
[2] Devdaha Med Coll & Res Inst, Rupandehi, Nepal
[3] Govt Inst Med Sci, Greater Noida, India
[4] Shadan Inst Med Sci, Hyderabad, Telangana, India
[5] BJ Med Coll, Ahmadabad, Gujarat, India
[6] Sri Ramachandra Inst Higher Educ & Res, Chennai, Tamil Nadu, India
[7] Batumi Shota Rustaveli State Univ, Batumi, Georgia
[8] St Vincent Hosp, Dept Internal Med, Worcester, MA USA
[9] Carle BroMenn Med Ctr, Dept Internal Med, Normal, IL USA
[10] St Mary Hosp, Dept Internal Med, Langhorne, PA USA
[11] Global Consortium Med Educ & Res, Pune, India
关键词
THERAPY; SOCIETY; SER-109; UPDATE;
D O I
10.1097/MS9.0000000000001410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5852 / 5854
页数:3
相关论文
共 23 条
[1]   Assessment of quality of life among patients with recurrent Clostridioides difficile infection treated with investigational oral microbiome therapeutic SER-109: secondary analysis of a randomized clinical trial (vol 6, e2253570, 2023) [J].
Garey, K. W. ;
Jo, J. ;
Gonzales-Luna, A. J. .
JAMA NETWORK OPEN, 2023, 6 (02)
[2]   Fecal Microbiota Transplantation in Inflammatory Bowel Disease [J].
Boicean, Adrian ;
Birlutiu, Victoria ;
Ichim, Cristian ;
Anderco, Paula ;
Birsan, Sabrina .
BIOMEDICINES, 2023, 11 (04)
[3]   Global prevalence of Clostridioides difficile in 17,148 food samples from 2009 to 2019: a systematic review and meta-analysis [J].
Borji, Soroush ;
Kadivarian, Sepide ;
Dashtbin, Shirin ;
Kooti, Sara ;
Abiri, Ramin ;
Motamedi, Hamid ;
Moradi, Jale ;
Rostamian, Mosayeb ;
Alvandi, Amirhooshang .
JOURNAL OF HEALTH POPULATION AND NUTRITION, 2023, 42 (01)
[4]   Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer [J].
Borody, Thomas J. ;
Eslick, Guy D. ;
Clancy, Robert L. .
CURRENT OPINION IN PHARMACOLOGY, 2019, 49 :43-51
[5]  
Cohen S., 2022, Antimicrob Steward Healthc Epidemiol, V2, DOI [10.1017/ash.2022.196, DOI 10.1017/ASH.2022.196]
[6]   Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial [J].
Cohen, Stuart H. ;
Louie, Thomas J. ;
Sims, Matthew ;
Wang, Elaine E. L. ;
Memisoglu, Asli ;
McGovern, Barbara H. ;
von Moltke, Lisa .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (20) :2062-2064
[7]   European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection [J].
Crobach, M. J. T. ;
Planche, T. ;
Eckert, C. ;
Barbut, F. ;
Terveer, E. M. ;
Dekkers, O. M. ;
Wilcox, M. H. ;
Kuijper, E. J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 :S63-S81
[8]   The burden of CDI in the United States: a multifactorial challenge [J].
Feuerstadt, Paul ;
Theriault, Nicolette ;
Tillotson, Glenn .
BMC INFECTIOUS DISEASES, 2023, 23 (01)
[9]   SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection [J].
Feuerstadt, Paul ;
Louie, Thomas J. ;
Lashner, Bret ;
Wang, Elaine E. L. ;
Diao, Liyang ;
Bryant, Jessica A. ;
Sims, Matthew ;
Kraft, Colleen S. ;
Cohen, Stuart H. ;
Berenson, Charles S. ;
Korman, Louis Y. ;
Ford, Christopher B. ;
Litcofsky, Kevin D. ;
Lombardo, Mary-Jane ;
Wortman, Jennifer R. ;
Wu, Henry ;
Aunins, John G. ;
McChalicher, Christopher W. J. ;
Winkler, Jonathan A. ;
McGovern, Barbara H. ;
Trucksis, Michele ;
Henn, Matthew R. ;
von Moltke, Lisa .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (03) :220-229
[10]   Burden of Clostridioides difficile infection (CDI)-a systematic review of the epidemiology of primary and recurrent CDI [J].
Finn, Elaine ;
Andersson, Fredrik L. ;
Madin-Warburton, Matthew .
BMC INFECTIOUS DISEASES, 2021, 21 (01)